Table 5.
Weighted multivariate analysis of the association between self-reported fever during pregnancy and developmental outcome. Results stratified by maternal report of anti-pyretic medication. The California CHARGE Study, 2003–2010
| Developmental outcome
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ASD
|
DD
|
TD
|
||||||||
| N | % | ORa | (95 % CI) | N | % | ORa | (95 % CI) | N | % | |
| Had fever but took anti-pyretic medication | 32 | 5.95 | 1.30 | (0.59, 2.84) | 13 | 7.98 | 2.05 | (0.78, 5.36) | 31 | 7.36 |
| Had fever but did not take anti-pyretic medication | 65 | 12.08 | 2.55 | (1.30, 4.99) | 19 | 11.66 | 2.73 | (1.19, 6.28) | 31 | 7.36 |
a
The ORs were adjusted for maternal report of influenza, type of insurance coverage during pregnancy, race/ethnicity in addition to the matching variables (child age, sex, and maternal place of residence at child birth). The reference group was mothers with no fever; none took medications for fever